Target intelligence / Profile preview

Dendritic cell–T cell immunological synapse (DC-T IS)

Target
DC-T IS
Molecular classification
Cellular interface, Protein-protein interaction network, Other
01

Overview

The dendritic cell–T cell immunological synapse is a highly organized, dynamic interface formed between a professional antigen-presenting cell (APC) and a T lymphocyte (Dustin, 2014). This structure is essential for the precise delivery of signals required for T cell activation, including the primary signal from the T cell receptor (TCR) binding to the peptide-MHC complex and secondary co-stimulatory or co-inhibitory signals (Grakoui et al., 1999). The synapse is spatially organized into supramolecular activation clusters (SMACs), which facilitate efficient signal transduction and cytokine secretion while maintaining specificity (Mellman & Steinman, 2001). In oncology, many therapies target molecules within this synapse, such as PD-1 or CTLA-4, to overcome tumor-induced immune suppression (Pardoll, 2012). Conversely, in autoimmune and inflammatory diseases, drugs like Abatacept modulate this interface to inhibit pathological T cell responses (Bluestone et al., 2006). Because it is a complex cellular interaction rather than a single protein, it represents a functional site for multi-target therapeutic intervention rather than a single molecular target.

Other names
Immune synapseISDC-T cell interfaceSupramolecular activation clusterSMACAntigen-presenting cell-T cell interface
02

Mechanism of action

Modulation of co-stimulatory and co-inhibitory signaling pathways within the organized interface between dendritic cells and T cells to regulate immune activation or tolerance.

03

Biological functions

Antigen presentationT cell activationSignal transductionImmune responseCell-cell communication
04

Disease associations

CancerInflammationInfectionAutoimmune disease
05

Safety considerations

Immune-related adverse events (irAEs)Cytokine release syndromeAutoimmune tissue damageOff-target immune suppression
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

PD-L1 expressionMHC class II expressionCD80/CD86 expressionT-cell receptor (TCR) repertoire diversityIFN-gamma levels

Beyond the preview

Go deeper on Dendritic cell–T cell immunological synapse (DC-T IS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dendritic cell–T cell immunological synapse (DC-T IS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call